Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review

Journal of Managed Care Pharmacy

Volumn 13, Issue 1, 2007, Pages 28-36

  Horning, Kristin K ^a,b,c   Hoehns, James D ^a,c   Doucette, William R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b East Des Moines Family Care Center   (United States)

^c Northeast Iowa Family Practice Residency Program   (United States)

Author keywords

Geriatrics; Long term care; Nursing homes; Practice guidelines

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; WARFARIN;

AGED; CHRONIC DISEASE; CHRONIC PATIENT; CONSULTATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEALTH SERVICE; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; PHARMACEUTICAL CARE; PHARMACIST; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; REVIEW; SELF EVALUATION; STATISTICAL SIGNIFICANCE; STROKE;

EID: 34249730525     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2007.13.1.28     Document Type: Review

References (31)

1. Centers for Disease Control and Prevention. Comorbid conditions by age, sex, and race. United States, 1981-2001. Available at: http:// 209.217.72.34/aging/TableViewer/tableView.aspx?ReportId=185. Accessed September 7, 2005.
2. National Committee for Quality Assurance. The state of health care quality, 2004. Available at: http://www.ncqa.org/communications/SOMC/ SOHC2004.pdf. Accessed September 2, 2005.
3. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995;273:1450-56.
4. Centers for Disease Control and Prevention. National diabetes fact sheet, 2005. Available at: http://www.diabetes.org/uedocuments/ NationalDiabetesFactSheetRev.pdf. Accessed September 7, 2005.
5. Follin SL, Hansen LB. Current approaches to the prevention and treatment of postmenopausal osteoporosis. Amer J Health Syst Pharm. 2003;60:883-904.
6. Jones A. The national nursing home survey: 1999 summary. National Center for Health Statistics. Vital Health Stat. 2002;13:1-116.
7. Freiman MP, Murtaugh CM. Interactions between hospital and nursing home use. Public Health Rep. 1995;100:546-54.
8. Tobias DE, Pulliam CC. General and psychotherapeutic medication use in 878 nursing facilities: a 1997 national survey. Consult Pharm. 1997;12:1401-08.
9. Wunderlich GS, Kohler PO, eds. Improving the Quality of Long-Term Care. Washington DC: National Academy Press; 2001.
10. Resnick B, Quinn C, Baxter S. Testing the feasibility of implementation of clinical practice guidelines in long-term care facilities. J Am Med Dir Assoc. 2004;5:1-8.
11. Zarowitz BJ, Hollenack K, Law S, Gurevitz S, O'Shea T. Cardiovascular risk reduction in frail elderly nursing home residents with diabetes [abstract]. Pharmacotherapy. 2005;25:1500.
12. Centers for Medicare & Medicaid Services. State operations manual. Appendix P: survey protocol for long term care facilities - part I. Revised August 2005. Available at: http://www.cms.hhs.gov/manuals/ Downloads/som107ap_p_ltcf.pdf. Accessed January 6, 2006.
13. Blau LA, Hoehns, JD. Acceptance and value of consultant pharmacists' interventions in long term care facilities. Poster presented at: 2005 ACCP Spring Meeting; April 11, 2005; Myrtle Beach, SC.
14. Harjivan C, Lyles A. Improved medication use in long-term care: building on the consultant pharmacist's drug regimen review. Am J Manag Care. 2002; 8:318-26.
15. American Diabetes Association. Summary of revisions for the 2005 clinical practice recommendations. Diabetes Care. 2005;28:54-S36.
16. National Diabetes Quality Improvement Alliance. National Diabetes Quality Improvement Alliance performance measurement set for adult diabetes. Approved January 21, 2005. Available at: www.nationaldiabetesalliance.org. Accessed September 2, 2005.
17. Smith SC Jr, Blair SN, Bonow RO, Brass LM, Cerqueira MD, Dracup K. AHA/ ACC scientific statement. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for health care professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104:1577-79.
18. Hirsh J, Guyatt G, Albers GW, Schünemann HJ. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines. Chest. 2004;126:172S-173S.
19. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult - summary article. Circulation. 2005;112:1825-52.
20. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.
21. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Executive Summary Bethesda, MD: National Institutes of Health. Report no.: NIH 01-3670. Published May 2001.
22. Grundy SM, Cleeman JI, Merz CN. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.
23. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis. Endocrine Practice. 2003;9:545-64.
24. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163:2716-24.
25. American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care. 2004;27:S72-S73.
26. Health Disparities Collaboratives. HDC topics: cardiovascular disease. Available at: http://www.healthdisparities.net/hdc/html/ collaboratives.topics.cvd.aspx. Accessed February 15, 2006.
27. Health Disparities Collaboratives. HDC topics: diabetes. Available at: http://www.healthdisparities.net/hdc/html/ collaboratives.topics.diabetes.aspx. Accessed February 15, 2006.
28. Strandberg TE, Pitkala KH, Berglind S, Nieminen MS, Tilvis RS. Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: a randomized, controlled trial. Am Heart J. 2006;152:585-92.
29. Jones A. The national nursing home survey: 1999 summary. National Center for Health Statistics. Vital Health Stat. 2002;13:1-116.
30. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA. 2005;294:716-24.
31. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med. 1997;157: 2089-96.